Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site’s displayed study total increased from 610,756 to 611,771; its stated geographic coverage remained the same.
    Difference
    0.1%
    Check dated 2026-11-15T02:11:12.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The homepage now reports 610,756 studies, up from 609,551, with locations across all 50 states and 226 countries and territories.
    Difference
    0.1%
    Check dated 2026-11-08T04:53:51.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site now reports 609,551 studies, up from 608,415, with locations across all 50 states and 226 countries and territories. The site revision advanced from v3.7.2 to v3.8.0.
    Difference
    0.3%
    Check dated 2026-11-01T02:00:10.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The homepage adds an NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” terminology and updates the number of studies listed from 607,349 to 608,415.
    Difference
    1%
    Check dated 2026-10-25T02:04:11.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site now reports 607,349 studies, up from 606,601, across all 50 states and 226 countries and territories. The displayed site revision also advanced from v3.7.1 to v3.7.2.
    Difference
    0.4%
    Check dated 2026-10-18T01:47:10.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The homepage now reports 606,601 studies across the listed locations, up from 605,599. The site revision is updated from v3.7.0 to v3.7.1.
    Difference
    0.4%
    Check dated 2026-10-11T02:18:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.